Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Selective tumor targeting reported for Bexxar

June 6, 1997

Lilly describes potent new SERM

June 6, 1997

Takeda describes GnRH antagonists

June 6, 1997

Milkhaus reports results of leukemia trial

June 6, 1997

Millennium issued U.S. patent for melanoma gene

June 5, 1997

PRIZM and Chiron begin gene therapy collaboration

June 5, 1997

Matrix Pharmaceutical's AccuSite recommended for approval in six European countries

June 4, 1997

Immunomedics' antibody therapy for non-Hodgkin's lymphoma shows promise in clinical trial

June 4, 1997

Banyu developing new anticancer agent

June 4, 1997

RCT issued U.S. patent for azonafide compounds

June 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...